Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    CRUSADE Score for Post-MI Bleeding Risk

    Stratifies bleeding risk after NSTEMI.
    Favorite
    When to Use
    Pearls/Pitfalls
    Why Use
    beats/min
    mm Hg
    %

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights

    Critical Actions

    • Risks and benefits of anti-thrombotic therapy and invasive treatment should be carefully considered in ALL patients presenting with NSTEMI or STEMI.
    • The CRUSADE bleeding risk score may have decreased utility in NSTEMI patients who receive 2 or more anti-thrombotic agents but do not undergo PCI.
    • Alternative bleeding risk scores may also be utilized in certain groups of patients.
    • Consider less invasive or high-risk anti-thrombotic dosage protocols in those STEMI/NSTEMI patients with increased risk for bleeding based on the CRUSADE bleeding risk score.
    Content Contributors